A trio of venture capital investors have backed laser cataract surgery business Lensar with $27m of equity financing.
Aisling Capital, Florida Growth and Florida Opportunity Funds took part in the equity round, while PDL BioPharma provided $60m of debt financing for the business.
Lensar said it planned to use the investment to extend its global commercialisation and growth.
Aisling managing partner and Lensar board chairman Steve Elms said, “The Lensar Laser System is extremely patient and surgeon friendly.
“When you look at the safety and enhanced accuracy for patients and how easily it is integrated into the practice for surgeons, the Lensar Laser System is the right technology at the right time for a growing market.
“We are pleased to continue investing in the best product in the industry.”
Last November Silicon Valley-based laser cataract surgery company OptiMedica Corp closed a $35m growth round of financing, with participation from all of the company’s existing venture backers.
They included Kleiner Perkins Caufield & Byers, Alloy Ventures, DAG Ventures, BlackRock Private Equity Partners and Bio*One Capital.
Copyright © 2013 AltAssets